Infratil Limited/Announcement
Infratil Limited logo

Ongoing Disclosure Notice - J Boyes

Insider Disclosure26 February 2025IFTUtilities

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Infratil Limited (IFT)

Date this disclosure made:

27-Feb-25

Date of last disclosure:

1-Aug-24

Director or senior manager giving disclosure

Full name(s):

Jason Boyes

Name of listed issuer:

Infratil Limited

Name of related body corporate (if applicable):

N/A

Position held in listed issuer:

Director and Chief Executive Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares in IFT

Nature of the affected relevant interest(s):

Registered holder and beneficial

owner

For that relevant interest-

Number held in class before acquisition or disposal:

1,426,695

Number held in class after acquisition or disposal:

1,902,885

Current registered holder(s):

N/A

Registered holder(s) once transfers are registered:

Jason Boyes

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-

Date of transaction:26-Feb-25

Nature of transaction: On market acquisition

Name of any other party or parties to the transaction (if known):

N/A

The consideration, expressed in New Zealand dollars, paid or received for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:

$4,999,995 ($10.50 per share)

Number of financial products to which the transaction related: 476,190

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:N/A

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

N/A

Nature of relevant interest:

N/A

For that relevant interest,-
Number held in class:

N/A

Current registered holder(s):

N/A

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

27-Feb-25

Name and title of authorised person:

Brendan Kevany, Company

Secretary

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • IPL — Investore Property Limited: D&O Ongoing Disclosure
    2024-12-16

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Investore Property Limited Date this disclosure made: 16-Dec-24 Date of last discl…”

  • IPL — Investore Property Limited: D&O Ongoing Disclosure
    2025-03-27

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Investore Property Limited Date this disclosure made: 27-Mar-25 Date of last discl…”

  • AFT — AFT Pharmaceuticals Limited: Disclosure of Directors and Senior Managers Relevant Intere
    2024-12-02

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: AFT Pharmaceuticals Limited Date this disclosure made: 2-Dec-24 Date of last discl…”